易瑞生物 (300942.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(易瑞生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 52,987,958.3051,403,742.2460,707,585.25114,802,872.7897,425,576.62180,667,811.50294,001,215.63
 营业收入(元) 52,987,958.3051,403,742.2460,707,585.25114,802,872.7897,425,576.62180,667,811.50294,001,215.63
二、营业总成本(元) 59,674,367.3390,638,271.8094,325,423.68145,145,412.24114,504,102.50140,599,690.64155,220,845.49
 营业成本(元) 16,613,723.2822,508,126.4245,522,665.6978,894,469.0651,740,896.3171,718,340.7896,408,256.89
 研发费用(元) 8,101,702.6022,115,785.9318,391,842.4550,872,526.7119,819,804.2425,119,453.5915,605,979.98
 营业税金及附加(元) 2,458,533.82366,882.15480,006.77400,700.75116,183.20889,124.151,191,075.42
 销售费用(元) 13,650,582.2822,734,058.2816,621,519.544,289,403.0816,643,865.9919,451,120.0918,520,216.53
 管理费用(元) 17,034,459.0530,524,931.0613,980,882.245,935,159.3130,990,280.9831,973,704.5723,386,279.42
 财务费用(元) 1,815,366.30-7,611,512.04-671,493.014,753,153.33-4,806,928.22-8,552,052.54109,037.25
  其中:利息费用(元) 961,366.082,357,213.211,180,065.092,407,876.10720,351.47458,829.51496,427.02
  其中:利息收入(元) 2,053,174.206,202,230.62-2,244,905.53800,606.04518,555.911,973,537.21271,715.23
 资产减值损失(元) -4,385,770.24---46,877,149.09-495,413.55--
 信用减值损失(元) -2,167,879.10-1,970,188.721,611,479.50-3,470,769.181,495,565.004,189,829.55-6,078,087.17
三、其他经营收益
 加:公允价值变动收益(元) -52,320.0799,750.00--2,636.28-5,566,729.561,900,000.00
 加:投资收益(元) -2,814,633.43-1,415,909.78-3,718,625.02-5,055,472.61857,827.255,803,006.681,070,843.57
  其中:对联营企业和合营企业的投资收益(元) -3,025,516.99-1,776,238.55-3,718,625.02-2,810,134.01-422,399.38-340,297.75-282,979.41
 资产处置收益(元) 454,128.942,114,281.0420,525.581,188,867.31132,275.43--
 其他收益(元) 4,307,198.372,840,272.502,070,494.552,958,777.216,549,876.101,657,742.183,607,191.32
四、营业利润(元) -11,293,364.49-50,258,758.50-33,534,213.82-77,928,919.98-8,541,031.9345,297,051.59139,280,317.86
 加:营业外收入(元) 114,422.85664,417.1393,239.42126,484.15-16,161.1027,963.06
 减:营业外支出(元) 1,064,802.00957,330.852,411.993,387,514.983,308.32863.23161.11
五、利润总额(元) -12,243,743.64-50,551,672.22-33,443,386.39-81,189,950.81-8,544,340.2545,312,349.46139,308,119.81
 减:所得税费用(元) 17,296,977.98-8,961,176.81-5,357,991.55-15,561,795.11-5,476,726.448,051,082.4425,209,821.95
六、净利润(元) -29,540,721.62-41,590,495.41-28,085,394.84-65,628,155.70-3,067,613.8137,261,267.02114,098,297.86
(一)按经营持续性分类
  持续经营净利润(元) -29,540,721.62-41,590,495.41-28,085,394.84-65,628,155.70-3,067,613.8137,261,267.02114,098,297.86
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -29,526,261.20-41,571,178.10-28,061,115.03-65,399,274.13-3,048,994.7837,284,787.37114,128,972.49
  少数股东损益(元) -14,460.42-19,317.31-24,279.81-228,881.57-18,619.03-23,520.35-30,674.63
 扣除非经常性损益后的净利润(元) -32,765,926.00-45,761,762.70-29,816,754.26-68,299,446.33-9,787,027.6535,260,531.35108,295,508.03
七、每股收益
 一、基本每股收益(元) -0.08-0.10-0.07-0.16-0.010.100.28
 二、稀释每股收益(元) -0.08-0.10-0.07-0.16-0.010.100.28
八、其他综合收益(元) -818,913.382,579,052.1843,114.26-1,077,881.641,102,016.23245,841.41-80,411.67
 归属于母公司股东的其他综合收益(元) -818,913.382,579,052.1843,114.26-1,077,881.641,102,016.23245,841.41-80,411.67
九、综合收益总额(元) -30,359,635.00-39,011,443.23-28,042,280.58-66,706,037.34-1,965,597.5837,507,108.43114,017,886.19
 归属于母公司所有者的综合收益总额(元) -30,345,174.58-38,992,125.92-28,018,000.77-66,477,155.77-1,946,978.5537,530,628.78114,048,560.82
 归属于少数股东的综合收益总额(元) -14,460.42-19,317.31-24,279.81-228,881.57-18,619.03-23,520.35-30,674.63
公告日期 2023-10-272023-08-302023-04-262023-04-262022-10-282022-08-302022-04-27
审计意见(境内) 标准无保留意见

前瞻产业研究院